All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts - PubMed (original) (raw)
All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts
R K Moorthy et al. J Virol. 1993 Mar.
Abstract
LMP-1, the Epstein-Barr virus latent membrane protein 1, is the only protein encoded by the virus that has been shown to have the properties of a transforming oncogene in rodent fibroblasts such as Rat-1 cells. LMP-1 is phosphorylated and proteolytically cleaved in Rat-1 cells in a manner similar to that seen in human lymphocytes. In this study, we demonstrate that all three major domains of LMP-1 (N-terminal, transmembrane, and C-terminal domains) are required for the ability to transform Rat-1 cells in culture, as assayed by loss of contact inhibition. This study is the first demonstration of a functional role for the C-terminal domain of LMP-1. Our analysis suggests that there are at least three distinct regions of the C terminus involved in signalling. Amino acids 306 to 334, which generate a toxic signal in the absence of amino acids 334 to 364, and the last 23 amino acids, 364 to 386, are essential for transformation. Biochemical analysis of the LMP-1 mutants with the three domains deleted indicate that the mutant N-terminal with the domain deleted is phosphorylated normally but is inefficiently cleaved compared with the wild-type LMP-1. The mutant with the transmembrane domain deleted is also phosphorylated but is not cleaved, showing that phosphorylation of LMP-1 does not require membrane association. The nontransforming mutant with the C-terminal domain deleted that lacks the last 23 amino acids is phosphorylated and cleaved. Therefore, these processing events alone are insufficient to generate a transforming signal.
Similar articles
- Biochemical, genetic, and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1.
Moorthy RK, Thorley-Lawson DA. Moorthy RK, et al. J Virol. 1993 May;67(5):2637-45. doi: 10.1128/JVI.67.5.2637-2645.1993. J Virol. 1993. PMID: 8386269 Free PMC article. - The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts.
Wang D, Liebowitz D, Kieff E. Wang D, et al. J Virol. 1988 Jul;62(7):2337-46. doi: 10.1128/JVI.62.7.2337-2346.1988. J Virol. 1988. PMID: 2836616 Free PMC article. - [Sequence analysis of the carboxy terminal of the Epstein-Barr virus LMP-1 oncogene in Epstein-Barr virus associated disorders].
Itakura O, Kikuta H. Itakura O, et al. Nihon Rinsho. 1997 Feb;55(2):467-72. Nihon Rinsho. 1997. PMID: 9046842 Review. Japanese. - Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
Kis LL, Takahara M, Nagy N, Klein G, Klein E. Kis LL, et al. Immunol Lett. 2006 Apr 15;104(1-2):83-8. doi: 10.1016/j.imlet.2005.11.003. Epub 2005 Dec 1. Immunol Lett. 2006. PMID: 16386314 Review.
Cited by
- Characterization of target gene regulation by the two Epstein-Barr virus oncogene LMP1 domains essential for B-cell transformation.
Mitra B, Beri NR, Guo R, Burton EM, Murray-Nerger LA, Gewurz BE. Mitra B, et al. mBio. 2023 Dec 19;14(6):e0233823. doi: 10.1128/mbio.02338-23. Epub 2023 Nov 27. mBio. 2023. PMID: 38009935 Free PMC article. - Preclinical study of LMP1-RNAi-based anti-tumor therapy in EBV-positive nasopharyngeal carcinoma.
Yuan Q, Chen BH, Huang DJ, Zhang R. Yuan Q, et al. Braz J Med Biol Res. 2023 Jul 21;56:e12638. doi: 10.1590/1414-431X2023e12638. eCollection 2023. Braz J Med Biol Res. 2023. PMID: 37493769 Free PMC article. - A Systematic Review of Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) Gene Variants in Nasopharyngeal Carcinoma.
Banko A, Miljanovic D, Lazarevic I, Cirkovic A. Banko A, et al. Pathogens. 2021 Aug 20;10(8):1057. doi: 10.3390/pathogens10081057. Pathogens. 2021. PMID: 34451521 Free PMC article. Review. - Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.
Wan Q, Song D, Li H, He ML. Wan Q, et al. Signal Transduct Target Ther. 2020 Jul 13;5(1):125. doi: 10.1038/s41392-020-00233-4. Signal Transduct Target Ther. 2020. PMID: 32661235 Free PMC article. Review. - Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update.
Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H, Nasrallah GK. Smatti MK, et al. Front Oncol. 2018 Jun 13;8:211. doi: 10.3389/fonc.2018.00211. eCollection 2018. Front Oncol. 2018. PMID: 29951372 Free PMC article. Review.
References
- Mol Cell Biol. 1987 Jul;7(7):2299-308 - PubMed
- J Virol. 1992 Jul;66(7):4612-6 - PubMed
- Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 - PubMed
- J Virol. 1984 Aug;51(2):411-9 - PubMed
- Proc Natl Acad Sci U S A. 1984 Nov;81(22):7207-11 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials